The changing landscape of clinical trial and approval processes in China

被引：0
|
作者：
Qing Zhou
Xiao-Yuan Chen
Zhi-Min Yang
Yi-Long Wu
机构：
[1] Qing Zhou and Yi-Long Wu are at the Guangdong Lung Cancer Institute,
[2] Guangdong General Hospital and Guangdong Academy of Medical Sciences,undefined
[3] 106 Zhongshan Er Road,undefined
[4] Guangzhou 510080,undefined
[5] China.,undefined
[6] Xiao-Yuan Chen and Zhi-Min Yang are at the Center for Drug Evaluation (CDE),undefined
[7] China Food and Drug Administration (CFDA),undefined
[8] 26 Xuanwumen Xidajie,undefined
[9] Beijing 100053,undefined
[10] China.,undefined
来源：
Nature Reviews Clinical Oncology | 2017年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The expansion of research and development of anticancer drugs in China has resulted in considerable delays in the approval of both clinical trials of novel agents, and the marketing approval of these agents once tested. In this Perspective, the authors describe the measures taken by the Chinese FDA to address these challenges in a rapidly developing research environment.
引用
收藏
页码：577 / 583
页数：6
相关论文
共 50 条
  • [1] The changing landscape of clinical trial and approval processes in China
    Zhou, Qing
    Chen, Xiao-Yuan
    Yang, Zhi-Min
    Wu, Yi-Long
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (09) : 577 - 583
  • [2] An analysis of the changing clinical trial landscape of melanoma
    Harcharik, S.
    Stensland, K.
    Moskalenko, M.
    Galsky, M.
    Sivendran, S.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 92 - 92
  • [3] Trial designs using real-world data: The changing landscape of the regulatory approval process
    Baumfeld Andre, Elodie
    Reynolds, Robert
    Caubel, Patrick
    Azoulay, Laurent
    Dreyer, Nancy A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1201 - 1212
  • [4] China's changing landscape
    Lubick, N
    [J]. GEOTIMES, 2005, 50 (10): : 18 - 21
  • [5] The changing landscape for clinical research
    Heinig, SJ
    Quon, ASW
    Meyer, RE
    Korn, D
    [J]. ACADEMIC MEDICINE, 1999, 74 (06) : 726 - 745
  • [6] The Changing Landscape of Clinical Psychology
    Johnson, James H.
    [J]. CLINICAL PSYCHOLOGY-SCIENCE AND PRACTICE, 2012, 19 (01) : 17 - 20
  • [7] The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021
    Chen Li
    Jun Hao
    Yitian Zheng
    Chuangshi Wang
    Jie Yang
    Wenyao Wang
    Kuo Zhang
    Chunli Shao
    Wen Hui
    Jiancheng Wang
    Wei Li
    Yi-Da Tang
    [J]. Diabetology & Metabolic Syndrome, 15
  • [8] Regulatory issues with multiplicity in drug approval: Principles and controversies in a changing landscape
    Benda, Norbert
    Brandt, Andreas
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (01) : 3 - 9
  • [9] The Changing Landscape of China's Consumerism
    Dong, Baomin
    [J]. Journal of Economics, 2015, 115 (01) : 95 - 97
  • [10] China and the changing landscape of the world economy
    Wang, Liming
    Zheng, Jinghai
    [J]. JOURNAL OF CHINESE ECONOMIC AND BUSINESS STUDIES, 2010, 8 (03) : 203 - 214
12345